The Centre of Research Excellence (CRE) to Reduce Inequality in Heart Disease focuses on improving the heart health and outcomes of groups and communities i.e. Regional Australians, Indigenous Australians and International Health
Dr. Joshua Byrnes is a research fellow at the Centre for Applied Health Economics as a Health Economist
within the School of Medicine. In this role he has been responsible for evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee (PBAC). This has involved critical appraisal of the efficacy, safety and economic impact of newly proposed medicines and pharmaceutical products to assist the PBAC in its decision making. Dr Byrnes has provided 9 full-economic evaluation reports with respect to a variety of health conditions.
His research interests include modelling costs and benefits of health care interventions, valuation of non-market (including health) goods, individual demand and decision making for health, and the role of taxation to achieve public health outcomes. Joshua has published a number of research articles regarding the cost, cost-effectiveness and cost impact of various medical and public health interventions.